Search All News
Columbia-led study hold promise for helping people find therapies that work.
Studies indicate that 29% to 46% of patients diagnosed with major depressive disorder show partial or no response to treatments.
This year’s Eric D. Hadar Distinguished Lecturer, Dr. Rajita Sinha, will present “Can We Rescue Stress and Trauma Related Pathophysiology in Addiction to Improve Treatment Outcomes?” on Nov. 16, 2022.
Patients who participate in fewer than two visits early in treatment are at risk for relapse, overdose, and possible death.
- October 27, 2021
This year’s Eric D. Hadar Lecture will take place on November 3, 2021 with Dr. Steven Shoptaw, who will present, “Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?”
- October 19, 2021
Columbia Psychiatry faculty, in partnership with avoMD, have developed an interactive smartphone application that provides point-of-care treatment algorithms for major depression.
Source:U.S. NewsJuly 19, 2021
Dr. Joshua Berman said electrical stimulation (ECT) seems to trigger the release of "neurotrophic" factors, which can help brain cells grow.
Source:Scripps National NewsJune 22, 2021
Dr. Meg Haney talks about research on drugs to address cannabis use disorder and current treatment available.
Source:Popular ScienceJune 6, 2021
Dr. Sidney Hankerson of the Columbia Wellness Center is helping to train Harlem faith leaders to bring Mental Health First Aid (MHFA) to African American and Latinx communities.
- May 24, 2021
A Columbia study looked at a short and promising approach that could encourage more health workers to get the mental health care they need via a method centered on a three-minute video.
Source:New York TimesMay 23, 2021
"The unbridled enthusiasm and commercial momentum generated by psychedelics are excessive and ill advised until we have more sound research," writes Dr. Jeffrey Lieberman.
Source:gizmodo.comJanuary 18, 2021
"Many patients report rapid improvement in mood, anxiety and hedonic function, which is what initially attracted the psychiatric profession to the use of ketamine," said Dr. Joshua Berman.
Source:MedscapeDecember 18, 2020
Diana Martinez discusses the interaction between cannabis and psychiatric disorders.
Source:MedscapeDecember 15, 2020
"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.